Article info
PDFShort report
Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease
- Correspondence to Dr Olga Pozdnyakova, Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA; opozdnyakova{at}bwh.harvard.edu
Citation
Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease
Publication history
- Received October 4, 2017
- Revised November 30, 2017
- Accepted March 10, 2018
- First published March 27, 2018.
Online issue publication
May 02, 2019
Article Versions
- Previous version (18 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.